AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 287 filers reported holding AMEDISYS INC in Q2 2022. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,928,487 | -43.5% | 127,714 | -44.7% | 0.00% | -50.0% |
| Q2 2023 | $21,117,063 | +1167.3% | 230,939 | +919.3% | 0.00% | – |
| Q1 2023 | $1,666,349 | -48.6% | 22,656 | -41.7% | 0.00% | -100.0% |
| Q4 2022 | $3,244,026 | -44.5% | 38,832 | -35.7% | 0.00% | -50.0% |
| Q3 2022 | $5,846,000 | -46.0% | 60,400 | -41.4% | 0.00% | -33.3% |
| Q2 2022 | $10,827,000 | -11.1% | 103,000 | +45.7% | 0.00% | +50.0% |
| Q1 2022 | $12,181,000 | -4.3% | 70,700 | -10.1% | 0.00% | – |
| Q4 2021 | $12,724,000 | -55.2% | 78,600 | -58.8% | 0.00% | -100.0% |
| Q3 2021 | $28,430,000 | +29.1% | 190,684 | +112.1% | 0.00% | +33.3% |
| Q2 2021 | $22,023,000 | +174.2% | 89,913 | +196.4% | 0.00% | +50.0% |
| Q1 2021 | $8,033,000 | -56.8% | 30,337 | -52.2% | 0.00% | 0.0% |
| Q4 2020 | $18,610,000 | -26.8% | 63,442 | -41.0% | 0.00% | -60.0% |
| Q3 2020 | $25,438,000 | +28.2% | 107,591 | +7.6% | 0.01% | +25.0% |
| Q2 2020 | $19,850,000 | +14.5% | 99,975 | +5.8% | 0.00% | -33.3% |
| Q1 2020 | $17,336,000 | +21.5% | 94,456 | +10.5% | 0.01% | +50.0% |
| Q4 2019 | $14,273,000 | +20.5% | 85,511 | -5.4% | 0.00% | 0.0% |
| Q3 2019 | $11,843,000 | -68.0% | 90,398 | -70.4% | 0.00% | -20.0% |
| Q2 2019 | $37,035,000 | +49.6% | 305,037 | +51.9% | 0.01% | -54.5% |
| Q1 2019 | $24,755,000 | +307.5% | 200,841 | +287.2% | 0.01% | +450.0% |
| Q4 2018 | $6,075,000 | -14.9% | 51,873 | -9.2% | 0.00% | -33.3% |
| Q3 2018 | $7,136,000 | -22.2% | 57,106 | -46.8% | 0.00% | -25.0% |
| Q2 2018 | $9,178,000 | +485.0% | 107,400 | +313.1% | 0.00% | – |
| Q1 2018 | $1,569,000 | -14.4% | 26,000 | -25.3% | 0.00% | – |
| Q4 2017 | $1,834,000 | -61.5% | 34,800 | -59.1% | 0.00% | -100.0% |
| Q3 2017 | $4,765,000 | -2.1% | 85,150 | +9.9% | 0.00% | 0.0% |
| Q2 2017 | $4,868,000 | +7.8% | 77,500 | -12.4% | 0.00% | 0.0% |
| Q1 2017 | $4,517,000 | +78.9% | 88,422 | +49.3% | 0.00% | +100.0% |
| Q4 2016 | $2,525,000 | +316.0% | 59,241 | +362.8% | 0.00% | – |
| Q3 2016 | $607,000 | -61.6% | 12,800 | -59.1% | 0.00% | -100.0% |
| Q2 2016 | $1,580,000 | -70.9% | 31,292 | -72.2% | 0.00% | -50.0% |
| Q1 2016 | $5,435,000 | +19.1% | 112,445 | -3.1% | 0.00% | 0.0% |
| Q4 2015 | $4,565,000 | -22.6% | 116,100 | -25.3% | 0.00% | 0.0% |
| Q3 2015 | $5,901,000 | -17.4% | 155,409 | -13.5% | 0.00% | -33.3% |
| Q2 2015 | $7,141,000 | +54.2% | 179,749 | +4.0% | 0.00% | 0.0% |
| Q1 2015 | $4,630,000 | -27.6% | 172,900 | -20.7% | 0.00% | +50.0% |
| Q4 2014 | $6,398,000 | +22.2% | 218,016 | -16.0% | 0.00% | 0.0% |
| Q3 2014 | $5,234,000 | -24.1% | 259,500 | -37.0% | 0.00% | -50.0% |
| Q2 2014 | $6,893,000 | +27.9% | 411,770 | +13.8% | 0.00% | +33.3% |
| Q1 2014 | $5,388,000 | +25.1% | 361,800 | +22.9% | 0.00% | +50.0% |
| Q4 2013 | $4,306,000 | -29.3% | 294,300 | -16.8% | 0.00% | -50.0% |
| Q3 2013 | $6,093,000 | +50.6% | 353,800 | +1.6% | 0.00% | +33.3% |
| Q2 2013 | $4,047,000 | – | 348,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVERBRIDGE PARTNERS LLC | 1,693,656 | $291,800,000 | 3.30% |
| Kent Lake Capital LLC | 30,000 | $5,169,000 | 3.21% |
| Lipe & Dalton | 22,802 | $3,929,000 | 1.92% |
| RK Capital | 54,900 | $9,459,000 | 1.86% |
| Millrace Asset Group, Inc. | 14,651 | $2,524,000 | 1.83% |
| Integral Health Asset Management, LLC | 40,000 | $6,892,000 | 1.79% |
| Bridge City Capital, LLC | 19,175 | $3,304,000 | 1.54% |
| Sivik Global Healthcare LLC | 20,000 | $3,446,000 | 1.42% |
| Bell Asset Management Ltd | 47,207 | $8,133,000 | 1.40% |
| Advantage Alpha Capital Partners LP | 53,680 | $9,249,000 | 1.38% |